The Elowitz Lab at Caltech @elowitzlab.bsky.social · 03/06/2025In a mouse model of Ras-driven liver cancer, systemic treatment with the circuits (lower row) reduced tumor burden compared to untreated controls (upper row). Much more to explore. 100
The Elowitz Lab at Caltech @elowitzlab.bsky.social · 03/06/2025We compared circuits (right) with Ras inhibitors (RMC-7977 and Sotorasib) by targeting mutant cells (magenta) co-cultured with wild-type Ras cells (green). Circuits were potent and selective. 100
The Elowitz Lab at Caltech @elowitzlab.bsky.social · 03/06/2025We tried many, many, many circuit designs, eventually generating ones that sensitively discriminate Ras mutant cancer cells. We also generated protease-activated proteases to amplify weak oncogenic signals. 100
The Elowitz Lab at Caltech @elowitzlab.bsky.social · 03/06/2025In this paradigm, engineered proteins are introduced into cancer and healthy cells using LNP-delivered mRNA. They then sense cancer markers (such as mutant Ras) and trigger engineered cell death effectors (caspases or gasdermins) only in cancer cells. (idealized schematic) 120